DOJ goes after $1.2B in health fraud, including telehealth, genetic testing

Regulators are primarily targeting laboratory owners and operators who paid illegal kickbacks and bribes in exchange for patient referrals from doctors working with fraudulent telemedicine and digital medical technology companies.